Literature DB >> 197024

Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells.

C Kaschka-Dierich, L Falk, G Bjursell, A Adams, T Lindahl.   

Abstract

The physical state of the intracellular Epstein-Barr virus DNA was characterized in four human lymphoblastoid cell lines, F-265, NC-37, U-303 L, and PG-1, derived from individuals without lymphoproliferative disease. For comparison, a previously investigated Burkitt lymphoma line, Raji, and a more recently established cell line of that origin, Rael, were also studied. The techniques employed were CsCl density gradient centrifugation, glycerol gradient centrifugation, and ethidium bromide-CsCl density gradient centrifugation in combination with nucleic acid hybridization, as well as electron microscopy contour length measurements of purified circular EBV DNA. All six cell lines contained multiple copies of covalently closed circular EBV DNA-molecules of the same size, as well as viral DNA with the properties of integrated DNA. No differences could be detected between the forms of EBV DNA present in cell lines derived from non-malignant sources and those present in lymphoma lines.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197024     DOI: 10.1002/ijc.2910200203

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.

Authors:  A Marchini; R Longnecker; E Kieff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.

Authors:  A Marchini; J I Cohen; F Wang; E Kieff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Epstein-Barr virus DNA is amplified in transformed lymphocytes.

Authors:  B Sugden; M Phelps; J Domoradzki
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

4.  Sites of sequence variability in Epstein-Barr virus DNA from different sources.

Authors:  L Rymo; T Lindahl; A Adams
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Size of the intracellular circular Epstein-Barr virus DNA molecules in infectious mononucleosis-derived human lymphoid cell lines.

Authors:  A Adams; G Bjursell; E Gussander; S Koliais; L Falk; T Lindahl
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

6.  Size heterogeneity of EBV and mitochondrial DNAs in Burkitt's lymphoma lines.

Authors:  D Kinchington; B E Griffin
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

7.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Integrated viral DNA sequences in Epstein-Barr virus-converted human lymphoma lines.

Authors:  M Andersson-Anvret; T Lindahl
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

9.  The extrachromosomal replication of Dictyostelium plasmid Ddp2 requires a cis-acting element and a plasmid-encoded trans-acting factor.

Authors:  B Leiting; I J Lindner; A A Noegel
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

10.  Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.

Authors:  F Wang; A Marchini; E Kieff
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.